Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-03-30Clinical Trial Update: Medtronic Observational Study in the "Real World" of Implantable Electronic Cardiac Devices
An observational real-world study by Medtronic evaluating implantable electronic cardiac devices in heart failure patients.
-
CLINICAL_TRIALS research · 2011-03-29Clinical Trial Update: Effect of Air Pollution in the Haifa Bay Area on Cardiovascular Morbidity and Mortality
This clinical trial investigates whether air pollution in the Haifa Bay Area influences cardiovascular morbidity and mortality, focusing on …
-
CLINICAL_TRIALS research · 2011-03-29Clinical Trial Update: Latin America Cardiac Resynchronization Therapy Study [Phase 4]
A Phase 4 clinical trial update for a Latin America Cardiac Resynchronization Therapy study sponsored by Medtronic. The trial concerns heart…
-
FDA approval · 2011-03-22FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2011-03-15Clinical Trial Update: The Usefulness of Growth Differentiation Factor 15 (GDF-15) for Risk Stratification in Cardiac Surgery
This completed trial evaluated whether Growth Differentiation Factor 15 (GDF-15) can improve risk stratification in patients undergoing card…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-03-08Clinical Trial Update: Left Atrial Distensibility to Predict Prognosis in Consecutive Patients
A clinical trial update examining whether left atrial distensibility can predict prognosis in patients with heart failure and atrial fibrill…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: CardioFit™ for the Treatment of Heart Failure [Phase 2]
Phase 2 clinical trial update for CardioFit™ in heart failure, reporting completion of the study; results are not provided in the available …
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels [Phase 3]
Phase 3 clinical trial update assessing safety and clinical experience with nesiritide (NATRECOR) in patients with worsening congestive hear…
-
CLINICAL_TRIALS research · 2011-03-03Clinical Trial Update: Left Atrial Distensibility Guiding Management in Advanced Chronic Heart Failure [NA]
This clinical trial update assesses whether left atrial distensibility can guide management in advanced chronic heart failure. Current statu…
-
CLINICAL_TRIALS research · 2011-02-21Clinical Trial Update: Developing and Assessing Competencies for Caregivers and Patients With Ventricular Assist Devices
This clinical trial update notes the completion of a study focused on developing and assessing competencies for caregivers and patients with…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: One-year Outcomes of Electromechanical Activation Time (EMAT)-Guided vs. Symptom-guided Heart Failure Therapy in Acute Heart Failure Syndrome (AHFS) Patients [NA]
This clinical trial update reports one-year outcomes comparing EMAT-guided heart failure therapy versus symptom-guided therapy in acute hear…
-
CLINICAL_TRIALS research · 2011-02-17Clinical Trial Update: Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure [NA]
An update on a clinical trial investigating regional ventriculo-arterial coupling in patients with chronic heart failure.
-
CLINICAL_TRIALS trial_result · 2011-02-15Clinical Trial Update: Exercise-induced Changes in Cardiac Function & Morphology [NA]
A completed clinical trial evaluating exercise-induced changes in cardiac function and morphology in patients with myocardial ischemia and r…
-
CLINICAL_TRIALS research · 2011-02-15Clinical Trial Update: Comparison Between Internal and External Chest Impedance Measurement
This document provides a clinical trial update on a study comparing internal versus external chest impedance measurements in patients with h…
-
CLINICAL_TRIALS research · 2011-02-14Clinical Trial Update: Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure [Phase 2, Phase 3]
The PTMA Device trial aiming to reduce mitral regurgitation in patients with heart failure (Phase 2/Phase 3) has been suspended; no safety o…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients [Phase 2]
A Phase 2 trial evaluating percutaneous reduction of mitral regurgitation in heart failure patients has been suspended.
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Regional Distribution of Ventilation in Patients With Chronic Heart Failure [NA]
A completed clinical trial update examining regional ventilation distribution in patients with chronic heart failure.
-
CLINICAL_TRIALS research · 2011-01-28Clinical Trial Update: Bosentan for Severe Mitral Valve Dysfunction [Phase 1, Phase 2]
This document indicates a Phase 1/Phase 2 clinical trial evaluating bosentan for severe mitral valve dysfunction, including secondary pulmon…
-
FDA approval · 2011-01-27FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for furosemide from Solco Healthcare LLC under an ANDA, authorizing a manufacturing or labeling chan…
-
FDA approval · 2011-01-27FDA Approved: FUROSEMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for furosemide from Ipca Laboratories Limited under an ANDA, signaling approval of changes to the ge…
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., updating or adding to the product's labeling and…
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for furosemide, a generic diuretic, under the existing ANDA.
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide filed by Hikma Pharmaceuticals USA Inc., updating the approved generic product un…
-
FDA approval · 2011-01-26FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., authorizing a change to the NDA (such as lab…
-
FDA approval · 2011-01-25FDA Approved: COREG CR — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for COREG CR (carvedilol phosphate) submitted by Waylis Therapeutics LLC.